Navigation Links
Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Results
Date:2/27/2012

ts disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA. Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S. For more information, please visit the Company's website at www.savient.com.

FORWARD-LOOKING STATEMENTSAll statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding the safety and efficacy of KRYSTEXXA®, status of our KRYSTEXXA marketing efforts and additional plans related thereto, market demand and reimbursement for KRYSTEXXA, our view of the refractory chronic gout ("RCG") market size, and our market expansion plans including our MAA filing before the EMA are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our assessment and interpretation of the currently available data and information, current expectations, assumptions, estimates and projections about our business and the biopharmaceutical and specialty pharmaceutical industries in which we operate. Important factors that may affect our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Savient Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
2. Savient Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference
3. Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer
4. Savient Pharmaceuticals Appoints Experienced Pharmaceutical Executive, David Veitch as President of Savient Europe
5. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
6. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
7. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
8. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
9. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
10. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
11. Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... LONDON , September 4, 2015 ... & Vaccines  Allergic Rhinitis drugs ... revenues Where is the market for allergic ... this market? Visiongain ,s new report shows you ... opportunities and prospects. Our 326 page report ...
(Date:9/4/2015)... DUBLIN , Sep. 04, 2015 ... ) has announced the addition of the ... - December 7-8, 2015)" conference to their ... take participants through all of the constituent parts ... veterinary medicinal product for which a marketing authorisation ...
(Date:9/4/2015)... , Sep. 04, 2015 ... http://www.researchandmarkets.com/research/dvzsqg/investigation ) has announced the addition of ... Hyaluronate Market, 2010-2019" report to their ... long-chain polymer containing repeating disaccharide units of ... fluid and cartilage matrix, sodium hyaluronate can ...
Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2Investigation Report on China's Sodium Hyaluronate Market 2015 2
... Aug. 18, 2011 /PRNewswire-Asia/ -- VacChina 2011 - ... largest vaccine meeting - - ... the opportunities of development of novel vaccine R&D and manufacturing technologies ... on March 1, 2011, that the national regulatory authority of China ...
... Reportlinker.com announces that a new market research ... Cancer Nucleic Acid Testing ... report presents an overview of the clinical significance ... well as listings of companies developing and marketing ...
Cached Medicine Technology:VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies 2
(Date:9/4/2015)... ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... involving the Pope’s upcoming trip to the United States. , Yisrayl lays out what he ... the Vatican and society is. Yisrayl also provides the meaning of his own name and ...
(Date:9/4/2015)... ... September 04, 2015 , ... EMED Jamaica Global Ltd. ... it has entered into a multi-year agreement with Health City Cayman Islands. , ... link between American healthcare, Jamaican healthcare and Health City Cayman Islands to deliver ...
(Date:9/3/2015)... WI (PRWEB) , ... September 04, 2015 , ... ... month of September. , "There are so many children and adults who don't ... Wisconsin," says Dr. Sara Mahalko-Leonhardt. "We love holding our annual Coat Drive to help ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to announce a ... norm not the exception. , St. Jude was recently named one of the nation’s ... making it one of only 10 hospitals in the state to earn the distinction. ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... Inc. , a privately held medical technology company that will bring low-cost cancer ... markets worldwide. , Preora’s proprietary and automated technology platform detects and measures ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:AlignLife is Helping to Keep the Community Warm This Winter 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3
... Reporter , FRIDAY, Feb. 11 (HealthDay News) -- A year before ... leukemia, a 19-year-old girl from Milwaukee had her cheek swabbed at ... by becoming his bone marrow donor. Munroe, 31, of Colleyville, ... head hurt a lot, and he began to feel very lethargic. ...
... University have discovered similarities between child soldier trauma ... Northern Ireland,s Troubles. Post-graduate students from ... Psychology at Queen,s recently travelled to Uganda to ... analysed the levels of post-traumatic stress among ex-soldiers, ...
... Reporter , THURSDAY, Feb. 10 (HealthDay News) -- Actress Denise ... show host Ann Curry hit the catwalk in fire-engine red. ... a cherry Donna Karan number, while hip-hop star Eve rocked ... annual Red Dress Collection fashion show in New York City, ...
... 10, 2011) Scientists at Virginia Commonwealth University Massey ... multiple myeloma that pairs two targeted agents to kill ... of the journal "Blood," are the first to demonstrate ... in vitro and in vivo. Multiple myeloma ...
... , THURSDAY, Feb. 10 (HealthDay News) -- Sustained ... decrease in adult smoking rates, from 22.1 percent in 1999 ... During that same time, the adult smoking rate in the ... percent, according to the U.S. Centers for Disease Control and ...
... Feb. 10, 2011 The realization of medically treating ... diseases in existence: tuberculosis. New findings by UT ... and the dosage routinely used to treat children with the ... to be effective. The findings, available online and ...
Cached Medicine News:Health News:Marrow Donation From Teenage Stranger Saves Man's Life 2Health News:Marrow Donation From Teenage Stranger Saves Man's Life 3Health News:Child soldier trauma in Uganda shares similarities with Northern Ireland 2Health News:Stars Strut on the Runway for Women's Heart Health 2Health News:Stars Strut on the Runway for Women's Heart Health 3Health News:VCU Massey first to combine targeted agents to kill multiple myeloma cells 2Health News:Homogeneous tuberculosis treatment ineffective in children, UT Southwestern researchers find 2
... easy-to-steer Bart EPXT catheter offers an ... curve control for faster, more accurate ... supplies exceptional levels of tip response ... small, medium and long-reach curves provides ...
... Mapping. Biosense Webster offers a complete ... SANTORO Fixed Catheter is designed for ... the coronary sinus. The pair of ... tip permit pacing in the coronary ...
Standard Deflectable Catheters...
Standard Deflectable Catheters...
Medicine Products: